Zentiva as is a Slovakia-based company engaged in generic pharmaceuticals business sector. The Company develops, manufactures, and sells generic medicinal products, primarily used in primary care sector. Its portfolio includes preparations for various therapeutic areas, including cardiovascular system, womenâ€™s healthcare, respiratory system, antimicrobials, urological system, central nervous system, pain, and gastrointestinal system.

Employees

Sector

Pharmaceuticals

More about the company

End-of-day quote Bratislava S.E. Other stock markets 06/07/2026			5-day change	1st Jan Change
31.00 ^EUR	0.00%		0.00%	+3.33%

03-16	Zentiva publishes 2025 sustainability report reinforcing commitment to people, partners and the planet	RE
02-23	Zentiva as responds to EU court decision on UWWTD	RE

Market Cap	243M 213M 197M 182M 343M 23.41B 347M 2.36B 922M 11.47B 912M 893M 39.61B	P/E 2017	7.27x	P/E 2018	177x
Enterprise Value	242M 212M 197M 181M 341M 23.33B 346M 2.35B 919M 11.43B 909M 890M 39.48B	EV / Sales 2017	3.97x	EV / Sales 2018	11.2x
Free-Float	4.05%	Yield 2017	13.8%	Yield 2018	-

03-16	Zentiva publishes 2025 sustainability report reinforcing commitment to people, partners and the planet	RE
02-23	Zentiva as responds to EU court decision on UWWTD	RE
11/09/25	Deals of the Day-Mergers and acquisitions	RE
11/09/25	Deals of the Day-Mergers and acquisitions	RE
11/09/25	Zentiva announces sale from Advent to GTCR	RE
11/09/25	Private equity firm Advent to sell drugmaker Zentiva to GTCR	RE
11/09/25	Deals of the Day-Mergers and acquisitions	RE
11/09/25	Private equity GTCR strikes $4.8 billion deal to buy Zentiva, FT reports	RE
11/09/25	Advent strikes $4.8 billion deal to sell Zentiva to GTCR, FT reports	RE
11/09/25	Advent strikes EUR4.1bn deal to sell generic drugmaker Zentiva to GTCR - FT	RE
20/08/25	India's Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5 billion, Economic Times reports	RE
20/08/25	India's Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5 billion, Economic Times reports	RE
21/02/13	Wood Pharma Holding a.s. completed the acquisition of Hlohovec Production Plant from Zentiva A.S..	CI

3 months	+3.33%
6 months	+3.33%
Current year	+3.33%

Zentiva, Stock

Stocks

1SKF401E

SK1120004439

Pharmaceuticals

Valuation: Zentiva,

Chart: Zentiva,

Latest news : Zentiva,

Press Releases: Zentiva,

Quotes and Performance

Course Extremes

Managers and Directors: Zentiva,

Generic Pharmaceuticals

Financials

Company Profile

1 month	31	31
Current year	29	33
1 year	29	45
3 years	24	45
5 years	11	45
10 years	11	370

Manager	Title	Age	Since
Thomas Cornelis Koene CEO	Chief Executive Officer	-	12/11/2015
Hacho Agop Hatchikian PRN	Corporate Officer/Principal	-	18/08/2022

Director	Title	Age	Since
Mojmír Krutý BRD	Director/Board Member	-	08/07/2013
Martin Albert BRD	Director/Board Member	-	18/10/2018
Kenneth Lynard BRD	Director/Board Member	58	15/11/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ZENTIVA,	0.00%	0.00%	+3.33%	+3.33%	57.3M
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.88%	-0.33%	+15.91%	+76.75%	48.88B
OTSUKA HOLDINGS CO., LTD.	-0.99%	+0.09%	+67.97%	+107.92%	35.72B
CIPLA LIMITED	-1.19%	-1.54%	-3.32%	+34.97%	12.02B
ZYDUS LIFESCIENCES LIMITED	-1.42%	-2.59%	+17.78%	+83.59%	11.84B
KRKA, D. D.	-1.87%	+0.94%	+34.42%	+136.73%	8.95B
ONO PHARMACEUTICAL CO., LTD.	+0.33%	+0.69%	+52.07%	-6.98%	6.91B
GEDEON RICHTER	-0.34%	-2.25%	+14.42%	+31.69%	6.78B
GLENMARK PHARMACEUTICALS LIMITED	-1.99%	-4.34%	+1.85%	+178.80%	6.57B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-5.44%	-2.89%	-32.00%	+9.46%	5.81B
Average	-1.37%	-1.19%	+17.24%	+65.63%	14.35B
Weighted average by Cap.	-1.18%	-0.03%	+27.65%	+81.08%

	2017	2018
Net sales	143M 125M 116M 107M 201M 13.74B 204M 1.38B 541M 6.73B 536M 524M 23.25B	36.17M 31.71M 29.38M 27.04M 50.99M 3.48B 51.61M 351M 137M 1.71B 136M 133M 5.9B
Net income	77.98M 68.35M 63.33M 58.29M 110M 7.51B 111M 756M 296M 3.68B 293M 286M 12.71B	2.29M 2.01M 1.86M 1.71M 3.23M 221M 3.27M 22.2M 8.69M 108M 8.6M 8.41M 373M
Net Debt	-0.09 -0.08 -0.07 -0.07 -0.13 -8.86 -0.13 -0.89 -0.35 -4.34 -0.35 -0.34 -14.99	-0.77 -0.68 -0.63 -0.58 -1.09 -74.54 -1.1 -7.5 -2.94 -36.53 -2.91 -2.84 -126.14